Diex Recherche

What Diex Recherche does

Diex Recherche is a privately held Canadian clinical research site network founded in 2006 and headquartered in Sherbrooke, Quebec. The company operates six integrated clinic sites across Quebec (Sherbrooke East and West, Quebec City, Victoriaville, Joliette, and Trois-Rivières) under unified SOPs and leadership, and conducts Phase 1 through Phase 4 clinical trials for pharmaceutical companies and Contract Research Organizations. Service offerings span protocol acquisition, budget negotiation, regulatory affairs, patient recruitment, study coordination, and data management, supported by a database of more than 100,000 participants and on-site medical equipment including centrifuges, freezers, ECG, ultrasound, spirometer, endoscopy, FibroScan, DXA scan, and MRI access. The company employs over 160 professionals including 60+ physicians and, in January 2026, opened an 11-bed Phase 1 Clinical Trial Unit with 24/7 staffing to extend into early-phase research.

Diex generates revenue through negotiated contracts with pharmaceutical sponsors and CROs for clinical trial conduct, functioning as a fee-for-service professional services provider. No public pricing is disclosed, and participant compensation (travel reimbursement and pro-rata payments) is a cost of operations rather than a revenue stream. Go-to-market is enterprise field sales targeting pharma and CRO sponsors, supplemented by a physician network of 60+ investigators and direct-to-patient recruitment through clinic websites and community outreach. Since 2019 the company has been a member of hyperCORE International LLP, the second-largest global clinical research site network, which expands its access to multi-jurisdictional sponsor relationships and shared operational practices.

Name

Diex Recherche

Legal name

Diex Recherche

Website

https://diex.ca

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

101–250 employees

Short description

Diex Recherche is a private Canadian clinical research site network operating six Quebec sites, conducting Phase 1-4 trials for pharmaceutical sponsors and CROs with 160 professionals and 100,000+ patient database.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

akta.pro secondary industry

Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI)

Keywords

• Clinical research services
• Clinical trials
• Phase 1 trials
• Patient recruitment
• Clinical study site

Headquarters

HQ city

Sherbrooke

HQ country

Canada

HQ region

North America

Offices6 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Trial Services for Sponsors: Diex Recherche operates as a clinical research site network providing Phase 1-4 trial services to pharmaceutical companies and CROs. They handle study initiation, patient recruitment, data collection, and regulatory compliance. Revenue is generated through negotiated contracts with sponsors for conducting clinical trials.
2. Participant Compensation: Clinical trial participants receive experimental treatments free of charge, travel reimbursement, and prorata compensation for their participation time. This is a cost to the company rather than a revenue stream.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Diex Recherche is a private clinical research site network operating six sites across Quebec, Canada. Founded in 2006, the company conducts Phase I–IV clinical trials for pharmaceutical sponsors and CROs, offering patient recruitment, regulatory affairs, and study coordination through a turnkey integrated model under unified SOPs. The organization also runs a dedicated Phase 1 Clinical Trial Unit and maintains a proprietary participant database exceeding 100,000 individuals.

Product overview

Diex Recherche is a private clinical research company conducting Phase I-IV clinical trials across six sites in Quebec (Sherbrooke East/West, Quebec City, Victoriaville, Joliette, and Trois-Rivières). The company operates a modern Phase 1 Clinical Trial Unit with 11 beds and 24/7 staffing, supported by medical equipment capabilities and a database of over 100,000 patients. Services include comprehensive clinical trial management with secure digital systems (eSource, electronic records), specialized diagnostic services, and dedicated participant recruitment. The company employs over 160 professionals and has conducted 508+ clinical trials.

Differentiator

Problem solved

Functional benefit

Products and services

• Phase 1 Clinical Trial Unit
• Clinical Trials Phase I–IV
• Patient Database and Recruitment Services
• Regulatory Affairs Services
• Turnkey Integrated Site Network Services

Quantifiable outcome

• 4-6 weeks from regulatory package to First Subject First Visit (FSFV)
• +3 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Nestlé Health SciencecoreStrategic or Co-development Partner · 18 November 2021Nestlé Health Science initiated a fully virtual study on ketogenic treatment for migraines with DIEX Recherche conducting the clinical trial.
• Immune BiosolutionscoreStrategic or Co-development Partner · 20 April 2020Partnership to fight COVID-19 with Immune Biosolutions, Diex Recherche, Université de Sherbrooke and Keyrus Life Science collaborating on research efforts.
• Université de SherbrookecoreStrategic or Co-development Partner · 20 April 2020Collaboration with the Faculty of Medicine and Health Sciences of Université de Sherbrooke for COVID-19 research partnership.
• Keyrus Life ScienceminorStrategic or Co-development Partner · 20 April 2020Partnership to fight COVID-19 combining clinical research capabilities with data and consulting expertise.
• hyperCORE International LLPcoreStrategic or Co-development Partner · 9 April 2019DIEX is part of hyperCORE International LLP, forming the second largest site network of highly awarded and experienced Clinical Research Site Organizations globally.
• Quebec Multi-Soins clinicminorOthers · 16 April 2018DIEX Group acquired the Quebec Multi-Soins clinic to expand its clinical research capabilities in Quebec City.

Scale indicators10 records

Recent moves10 records

Expansion highlights6 records

Broad incumbents

• IQVIA: Largest global CRO with embedded site network and clinical trial delivery across all phases — broader portfolio but directly competes for Phase 1-4 trial placement at sponsors Diex serves.
• ICON plc: Global CRO offering full-service Phase 1-4 clinical development and site management services — broad incumbent competing for the same sponsor budget Diex accesses.
• Syneos Health: Global clinical and commercial solutions provider with Phase 1-4 trial conduct capabilities and dedicated site solutions — overlapping customer base of pharma sponsors but at much greater scale.
• Worldwide Clinical Trials: Mid-to-large CRO conducting Phase 1-4 trials across multiple therapeutic areas for biopharma sponsors — directly comparable Phase 1-4 clinical operations service line.
• Charles River Laboratories: Large CRO with early-phase clinical and site services alongside broader discovery/manufacturing offerings — comparable in clinical trial services but with much broader scope.

Direct peers

• Velocity Clinical Research: Multi-site clinical research organization operating dedicated research sites across the US, conducting Phase 1-4 trials with integrated patient recruitment — direct functional analogue to Diex's site-network model, just at much larger scale.
• ClinEdge: Site management organization providing site network services, patient recruitment, and clinical trial coordination for sponsors — comparable site-network operating model.
• Flourish Research: Multi-site clinical research organization operating integrated research sites with large patient databases for Phase 1-4 trials — same business model as Diex (integrated site network with recruitment infrastructure) but US-focused.
• hyperCORE International: Second-largest global site alliance of which Diex is a member; the consortium model and shared operating capabilities make other member sites direct functional peers in multi-region trial conduct.

Regional players

• Pharmanetwork Clinical Trials (Manna Research): Canadian multi-site clinical research organization operating similarly structured research clinics — same integrated site-network business model within Canada, key regional competitor.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/in/suzie-talbot-70ba1413
• Xx.com/DiexRecherche
• Facebookfacebook.com/diexrecherche.ca

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Diex Recherche